The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Research · 2024-01 · 7
DOI: 10.34133/research.0351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Research, online erschienen am 12.06.2024. Verfasst von Jie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, The Scientific Research Program of FuRong Laboratory, the science and technology innovation Program of Hunan Province.
Abstract (Originalsprache)
The tricarboxylic acid (TCA) cycle is capable of providing sufficient energy for the physiological activities under aerobic conditions. Although tumor metabolic reprogramming places aerobic glycolysis in a dominant position, the TCA cycle remains indispensable for tumor cells as a hub for the metabolic linkage and interconversion of glucose, lipids, and certain amino acids. TCA intermediates such as citrate, α-ketoglutarate, succinate, and fumarate are altered in tumors, and they regulate the tumor metabolism, signal transduction, and immune environment to affect tumorigenesis and tumor progression. This article provides a comprehensive review of the modifications occurring in tumor cells in relation to the intermediates of the TCA cycle, which affects tumor pathogenesis and current therapeutic strategy for therapy through targeting TCA cycle in cancer cells.
Autor:innen und Institutionen
- The Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Furong Labratory, Changsha, Hunan, China.
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Cong Peng
Förderung
- National Natural Science Foundation of China
- The Scientific Research Program of FuRong Laboratory
- the science and technology innovation Program of Hunan Province
Zitieren
APA
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024). The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy. Research, 7. https://doi.org/10.34133/research.0351
Vancouver
Wu J, Liu N, Chen J, Tao Q, Li Q, Li J, et al. The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy. Research. 2024;7. doi:10.34133/research.0351
BibTeX
@article{Wu2024,
author = {Wu, Jie and Liu, Nian and Chen, Jing and Tao, Qian and Li, Qiuqiu and Li, Jie and Chen, Xiang and Peng, Cong},
title = {The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy},
journal = {Research},
year = {2024},
volume = {7},
doi = {10.34133/research.0351}
}
EUVIMED